Novartis to develop salmon vaccine

I/SP first launched its own vaccine against pancreas disease (PD) in salmon, Norvax, in 2008. Now the group has given exclusive rights to a portion of its patent to rival Novartis.

This will help the aquaculture sector better combat PD, the group said in a statement.

“The aquaculture business is a priority at Novartis Animal Health and it is a business that we will continue to invest in,” said George Gunn, Global Head of Novartis Animal Health.

“We are pleased to have reached an agreement that allows Novartis to develop a vaccine based on new, innovative technology and that potentially will enable salmon producers in Norway, UK and Ireland to better manage pancreas disease.”